SCHEMBL4934278

SCHEMBL4934278

O=C1N=NC2=NC=NC2=N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10609471 0.67
SCHEMBL73936 0.66
SCHEMBL3143238 0.65
SCHEMBL11690678 0.62
SCHEMBL7617975 0.62 MPO (0.36)
SCHEMBL8662289 0.62 MPO (0.36)
SCHEMBL7487796 0.62 MPO (0.36)
SCHEMBL220383 0.62
SCHEMBL19640955 0.60
SCHEMBL2519606 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080096880-A1 Novel use of imidazotriazinones BAYER HEAKTHCARE AG (DE) 2008-04-24 US disclosed
EP-1519730-A1 NOVEL USE OF IMIDAZOTRIAZINONES Bayer HealthCare AG (DE) 2005-04-06 EP disclosed
WO-2004004736-A1 NOVEL USE OF IMIDAZOTRIAZINONES BAYER HEALTHCARE AG (DE) 2004-01-15 WO disclosed